Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period : Clinical Scenario-Based Practical Recommendations From A Group of Perinatal Psychiatry Authors
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved..
ABSTRACT: Many women with bipolar disorder experience episodes of illness or relapses over the perinatal period, especially in the immediate postpartum period. Risks associated with treated/untreated psychopathologies and fetal exposure to bipolar medications make the management of bipolar disorder during these periods challenging for clinicians and patients. In light of the available effectiveness and reproductive safety data, the current clinical update based on the opinions of a group of international perinatal psychiatry authors recommends general considerations and specific management strategies for each possible clinical scenario, including mixed features, predominant polarity, diagnosis of subtypes of bipolar disorder, severity of previous episodes, and risk of recurrence of mood episodes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Journal of clinical psychopharmacology - 43(2023), 5 vom: 01. Sept., Seite 434-452 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Uguz, Faruk [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 02.11.2023 Date Revised 02.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/JCP.0000000000001740 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361807708 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361807708 | ||
| 003 | DE-627 | ||
| 005 | 20231226085922.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/JCP.0000000000001740 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1205.xml |
| 035 | |a (DE-627)NLM361807708 | ||
| 035 | |a (NLM)37683233 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Uguz, Faruk |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period |b Clinical Scenario-Based Practical Recommendations From A Group of Perinatal Psychiatry Authors |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.11.2023 | ||
| 500 | |a Date Revised 02.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved. | ||
| 520 | |a ABSTRACT: Many women with bipolar disorder experience episodes of illness or relapses over the perinatal period, especially in the immediate postpartum period. Risks associated with treated/untreated psychopathologies and fetal exposure to bipolar medications make the management of bipolar disorder during these periods challenging for clinicians and patients. In light of the available effectiveness and reproductive safety data, the current clinical update based on the opinions of a group of international perinatal psychiatry authors recommends general considerations and specific management strategies for each possible clinical scenario, including mixed features, predominant polarity, diagnosis of subtypes of bipolar disorder, severity of previous episodes, and risk of recurrence of mood episodes | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Sharma, Verinder |e verfasserin |4 aut | |
| 700 | 1 | |a Boyce, Philip |e verfasserin |4 aut | |
| 700 | 1 | |a Clark, Crystal T |e verfasserin |4 aut | |
| 700 | 1 | |a Galbally, Megan |e verfasserin |4 aut | |
| 700 | 1 | |a Koukopoulos, Alexia |e verfasserin |4 aut | |
| 700 | 1 | |a Marsh, Wendy |e verfasserin |4 aut | |
| 700 | 1 | |a Stevens, Anja |e verfasserin |4 aut | |
| 700 | 1 | |a Viguera, Adele |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical psychopharmacology |d 1993 |g 43(2023), 5 vom: 01. Sept., Seite 434-452 |w (DE-627)NLM012629219 |x 1533-712X |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2023 |g number:5 |g day:01 |g month:09 |g pages:434-452 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/JCP.0000000000001740 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2023 |e 5 |b 01 |c 09 |h 434-452 | ||